RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 86 filers reported holding RUBIUS THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $0 | – | 60 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 2,618,351 | $41,187,000 | 42.64% |
| Flagship Pioneering Inc. | 38,296,526 | $602,404,000 | 26.08% |
| HARBOURVEST PARTNERS LLC | 1,973,756 | $31,048,000 | 5.81% |
| Artal Group S.A. | 2,833,791 | $44,576,000 | 1.80% |
| EcoR1 Capital, LLC | 463,152 | $7,285,000 | 0.74% |
| Cormorant Asset Management, LP | 600,000 | $9,438,000 | 0.54% |
| Nikko Asset Management Americas, Inc. | 1,254,158 | $19,728,000 | 0.39% |
| Leap Investments LP | 14,100 | $222,000 | 0.30% |
| ARK Investment Management | 698,402 | $10,986,000 | 0.28% |
| Baillie Gifford | 4,234,682 | $66,612,000 | 0.07% |